Warfarin Use Among Patients With Atrial Fibrillation (Q41669384)

6 October 2017

title

Warfarin use among patients with atrial fibrillation (English)

1 reference

6 October 2017

Warfarin Use Among Patients With Atrial Fibrillation (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

30 November 2024

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9412618

30 November 2024

H M Krumholz

1 reference

6 October 2017

L. M. Brass

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9412618

30 November 2024

J. M. Scinto

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9412618

30 November 2024

M. Radford

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9412618

30 November 2024

language of work or name

English

0 references

publication date

1 December 1997

1 reference

6 October 2017

December 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9412618

full work available at URL

30 November 2024

https://www.ahajournals.org/doi/full/10.1161/01.STR.28.12.2382

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

30 November 2024

1 reference

6 October 2017

1 reference

6 October 2017

1 reference

6 October 2017

page(s)

2382-2389

1 reference

Tissue plasminogen activator for acute ischemic stroke

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Drugs and surgery in the prevention of ischemic stroke

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Antithrombotic therapy in atrial fibrillation

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Canadian atrial fibrillation anticoaguiation (CAFA) study

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Antithrombotic therapy in atrial fibrillation

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Guidelines for medical treatment for stroke prevention. American College of Physicians

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Regional attitudes of generalists, specialists, and subspecialists about management of atrial fibrillation

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Anticoagulants for atrial fibrillation

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

The impact of clinical trials on the use of medications for acute myocardial infarction. Results of a community-based study

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Service provision and use of anticoagulants in atrial fibrillation.

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Warfarin for atrial fibrillation. The patient's perspective

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Commentary: Caution needed in introducing warfarin treatment.

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Anticoagulant-related intracerebral hemorrhage.

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

Failure of the International Normalized Ratio to generate consistent results within a local medical community

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

The international normalized ratio. A guide to understanding and correcting its problems

30 November 2024

1 reference

https://api.crossref.org/works/10.1161/01.STR.28.12.2382

30 November 2024

Identifiers

DOI

1 reference

6 October 2017

1 reference